Insight Inv LLC Bristol Myers Squibb CO Transaction History

Insight Inv LLC

$118 Million
Q3 2024

A detailed history of Insight Inv LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Insight Inv LLC holds 22,196 shares of BMY stock, worth $1.29 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

22,196

Previous 22,671 2.1%

Holding current value

$1.29 Million

Previous $941,000 22.0%

% of portfolio

0.97%

Previous 0.82%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $18,838 - $24,581	-475 Reduced 2.1%	22,196 $1.15 Million
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $84,525 - $111,279	-2,100 Reduced 8.48%	22,671 $941,000
Q1 2024 Apr 29, 2024	BUY	$47.98 - $54.4 $121,389 - $137,632	2,530 Added 11.38%	24,771 $1.34 Million
Q4 2023 Jan 22, 2024	SELL	$48.48 - $57.85 $26,906 - $32,106	-555 Reduced 2.43%	22,241 $1.14 Million
Q3 2023 Oct 27, 2023	SELL	$57.89 - $64.73 $30,971 - $34,630	-535 Reduced 2.29%	22,796 $1.32 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $17,520 - $19,453	275 Added 1.19%	23,331 $1.49 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $271,382 - $307,808	-4,130 Reduced 15.19%	23,056 $1.6 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $13,353 - $15,812	-195 Reduced 0.71%	27,186 $1.96 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $98 - $58,398	-760 Reduced 2.7%	27,381 $1.95 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $38,125 - $41,989	-525 Reduced 1.83%	28,141 $2.17 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $181,366 - $217,474	2,950 Added 11.47%	28,666 $2.09 Million
Q4 2021 May 09, 2022	BUY	$53.63 - $62.52 $1.38 Million - $1.61 Million	25,716 New	25,716 $1.6 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Inv LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Inv LLC with notifications on news.

Account